Subscribe To
Vigil neuroscience to present at stifel 2023 cns days
WATERTOWN, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to har...
March 22, 2023, 7:00 am
Brainstorm to announce fourth quarter and fiscal year 2022 financial results and provide a corporate update
NEW YORK , March 21, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for ...
March 21, 2023, 8:18 am
Tiziana life sciences receives positive coverage on foralumab in forbes article
Tiziana Life Sciences Ltd (NASDAQ:TLSA). said it has received positive coverage in an article on Forbes which highlighted foralumab, its unique intra...
March 17, 2023, 8:19 am
Clene to announce new cnm-au8® data from the healey als platform trial
Webcast set for 7:30 a.m. ET on March 9 SALT LAKE CITY, March 08, 2023 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, �...
March 8, 2023, 9:10 pm
Nkgen biotech announces formation of scientific advisory board to drive its pipeline strategy for natural killer cell therapies targeting neurodegenerative diseases
SANTA ANA, Calif., March 08, 2023 (GLOBE NEWSWIRE) — NKGen Biotech, a biotechnology company harnessing the power of the body’s immune system throu...
March 8, 2023, 6:27 pm
Labcorp (lh) focuses on high-growth areas amid currency woe
In its efforts to expand further, LabCorp (LH) is focusing more on high-growth opportunity areas such as neuro...
March 8, 2023, 12:02 pm
Why shares of anavex life sciences rose 12.4% in february
Anavex is a clinical-stage biotech stock with no revenue. The company's lead therapy is being tested to treat a host of ...
March 6, 2023, 8:21 pm
Former nfl neurologist joins algernon's program using dmt to treat traumatic brain injury
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has engaged Dr David Brody, an expert neurologist, as a consultant to support the company's clini...
March 2, 2023, 9:48 am
Vyant bio commences a cash preservation plan including a reduction in force
Continuing to Explore Strategic Alternatives CHERRY HILL, N.J., Feb. 03, 2023 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (“Vyant Bio” or “Company”) ...
February 3, 2023, 11:00 am
Fsd pharma submits clinical trial application for its multiple sclerosis treatment candidate lucid-ms
FSD Pharma Inc (CSE:HUGE, NASDAQ:HUGE) announced it has submitted a Clinical Trial Application (CTA) for a planned Phase-1 clinical trial for Lucid-MS...
January 17, 2023, 10:12 am
Neurocentria announces dr. thomas südhof to join the scientific advisory board
The appointment further strengthens the company’s scientific resources, including in neuronal function and synaptic transmission, which are central ...
January 13, 2023, 2:00 pm
Annexon to present at 41st annual j.p. morgan healthcare conference
BRISBANE, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of...
January 4, 2023, 6:30 am
Vigil neuroscience to present at the 41st annual j.p. morgan healthcare conference
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) — Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harn...
January 3, 2023, 12:00 pm
Centogene to participate in upcoming conferences in december
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner ...
December 1, 2022, 6:30 am
Alector presents results from first-in-human phase 1 study of al101 for the treatment of neurodegenerative diseases
AL101 is being developed to elevate progranulin (PGRN) levels with dosing regimens to be optimized for larger indications such as Alzheimer’s diseas...
November 29, 2022, 4:05 pm
Ac immune to present progress of alzheimer's disease programs targeting abeta and tau at the 15th ctad conference
Lausanne, Switzerland, November 2 3 , 202 2 – AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision medicine ...
November 23, 2022, 7:30 am
Centogene to participate in upcoming conferences in november
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner ...
November 10, 2022, 6:30 am
Clene to present at upcoming september investor conferences
SALT LAKE CITY, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) along with its subsidiaries “Clene” and its wholly owned subsidiary ...
August 30, 2022, 7:00 am
Brainstorm cell therapeutics: upcoming bla in als
Brainstorm Cell Therapeutics is a company developing NurOwn as an autologous stem cell-based treatment for ALS and MS. NurOwn's mechanism of action re...
August 21, 2022, 3:57 am
Theravance's (tbph) hypotension study misses primary goal
Theravance's (TBPH) phase III study on ampreloxetine for treating symptomatic nOH fails to meet its goal. The study benefitted patients with a rare ...
April 5, 2022, 2:18 pm